Rosella Ombrato

Rome, 00181, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X Syndrome.

Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X Syndrome.

Journal: Neurobiology of disease

Published: June 07, 2024

Molecular Insights Into Binding and Activation of the Human KCNQ2 Channel by Retigabine.

Molecular Insights Into Binding and Activation of the Human KCNQ2 Channel by Retigabine.

Journal: Frontiers in molecular biosciences

Published: December 19, 2021

Testing Fmr1 KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127.

Testing Fmr1 KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127.

Journal: Frontiers in molecular neuroscience

Published: July 31, 2021

Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening.

Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 17, 2021

Structure-based virtual screening to identify novel carnitine acetyltransferase activators.

Structure-based virtual screening to identify novel carnitine acetyltransferase activators.

Journal: Journal of molecular graphics & modelling

Published: May 07, 2020

Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches.

Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches.

Journal: Molecules (Basel, Switzerland)

Published: April 14, 2020

The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.

The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 22, 2020

Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model.

Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model.

Journal: ACS medicinal chemistry letters

Published: December 20, 2019

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors.

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors.

Journal: PloS one

Published: August 01, 2019

Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens.

Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens.

Journal: Journal of medicinal chemistry

Published: July 06, 2019

Molecular basis for the different interactions of congeneric substrates with the polyspecific transporter AcrB.

Molecular basis for the different interactions of congeneric substrates with the polyspecific transporter AcrB.

Journal: Biochimica et biophysica acta. Biomembranes

Published: February 23, 2018

A Novel Multi-step Virtual Screening for the Identification of Human and Mouse mPGES-1 Inhibitors.

A Novel Multi-step Virtual Screening for the Identification of Human and Mouse mPGES-1 Inhibitors.

Journal: Molecular informatics

Published: February 10, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026